172 related articles for article (PubMed ID: 10381143)
21. The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.
Fukaya N; Mochizuki K; Tanaka Y; Kumazawa T; Jiuxin Z; Fuchigami M; Goda T
Eur J Pharmacol; 2009 Dec; 624(1-3):51-7. PubMed ID: 19818342
[TBL] [Abstract][Full Text] [Related]
22. Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.
Johnston PS; Feig PU; Coniff RF; Krol A; Kelley DE; Mooradian AD
Diabetes Care; 1998 Mar; 21(3):416-22. PubMed ID: 9540025
[TBL] [Abstract][Full Text] [Related]
23. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
[TBL] [Abstract][Full Text] [Related]
24. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats.
Cefalu WT; Wang ZQ; Zhang XH; Baldor LC; Russell JC
J Nutr; 2002 Jun; 132(6):1107-14. PubMed ID: 12042418
[TBL] [Abstract][Full Text] [Related]
25. Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study.
Drent ML; Tollefsen AT; van Heusden FH; Hoenderdos EB; Jonker JJ; van der Veen EA
Diabetes Nutr Metab; 2002 Jun; 15(3):152-9. PubMed ID: 12173729
[TBL] [Abstract][Full Text] [Related]
26. Postprandial glycemic control, hormonal effects and carbohydrate malabsorption during long-term administration of the alpha-glucosidase inhibitor miglitol.
Lembcke B; Diederich M; Fölsch UR; Creutzfeldt W
Digestion; 1990; 47(1):47-55. PubMed ID: 2292349
[TBL] [Abstract][Full Text] [Related]
27. Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men.
Aoki K; Kato H; Terauchi Y
Endocr J; 2007 Dec; 54(6):1009-14. PubMed ID: 18048991
[TBL] [Abstract][Full Text] [Related]
28. In vitro study of the effect of miglitol on carbohydrate digestion and intestinal metabolism in normal and non-insulin-dependent diabetic rats.
Tormo MA; Ropero MF; Nieto M; Martinez IM; Campillo JE
Can J Physiol Pharmacol; 1996 Nov; 74(11):1196-203. PubMed ID: 9028577
[TBL] [Abstract][Full Text] [Related]
29. Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat.
Russell JC; Ravel D; Pégorier JP; Delrat P; Jochemsen R; O'Brien SF; Kelly SE; Davidge ST; Brindley DN
J Pharmacol Exp Ther; 2000 Nov; 295(2):753-60. PubMed ID: 11046115
[TBL] [Abstract][Full Text] [Related]
30. alpha-Glucosidase inhibition by miglitol in NIDDM patients.
Kingma PJ; Menheere PP; Sels JP; Nieuwenhuijzen Kruseman AC
Diabetes Care; 1992 Apr; 15(4):478-83. PubMed ID: 1499461
[TBL] [Abstract][Full Text] [Related]
31. Effect of alpha-glucosidase inhibition on glucose profiles in insulin dependent diabetes.
Hillman RJ; Scott M; Gray RS
Diabetes Res; 1989 Feb; 10(2):81-4. PubMed ID: 2663321
[TBL] [Abstract][Full Text] [Related]
32. Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.
Scott LJ; Spencer CM
Drugs; 2000 Mar; 59(3):521-49. PubMed ID: 10776834
[TBL] [Abstract][Full Text] [Related]
33. Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
Goda T; Suruga K; Komori A; Kuranuki S; Mochizuki K; Makita Y; Kumazawa T
Br J Nutr; 2007 Oct; 98(4):702-10. PubMed ID: 17537288
[TBL] [Abstract][Full Text] [Related]
34. Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I diabetes mellitus.
Dimitriadis G; Hatziagellaki E; Alexopoulos E; Kordonouri O; Komesidou V; Ganotakis M; Raptis S
Diabetes Care; 1991 May; 14(5):393-8. PubMed ID: 2060451
[TBL] [Abstract][Full Text] [Related]
35. The effect of two new alpha-glucosidase inhibitors on metabolic responses to a mixed meal in normal volunteers.
Kennedy FP; Miles JM; Heiling V; Gerich JE
Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):633-40. PubMed ID: 3326689
[TBL] [Abstract][Full Text] [Related]
36. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
Madar Z
J Nutr; 1989 Dec; 119(12):2023-9. PubMed ID: 2695605
[TBL] [Abstract][Full Text] [Related]
37. Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.
Pagano G; Marena S; Corgiat-Mansin L; Cravero F; Giorda C; Bozza M; Rossi CM
Diabete Metab; 1995 Jun; 21(3):162-7. PubMed ID: 7556806
[TBL] [Abstract][Full Text] [Related]
38. Effects of chronic ethanol consumption in atherosclerosis-prone JCR:LA-corpulent rat.
Russell JC; Amy RM; Manickavel V; Dolphin PJ
Arteriosclerosis; 1989; 9(1):122-8. PubMed ID: 2643422
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR
Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668
[TBL] [Abstract][Full Text] [Related]
40. Concurrent Therapy with a Low-carbohydrate Diet and Miglitol Remarkably Improved the Postprandial Blood Glucose and Insulin Levels in a Patient with Reactive Hypoglycemia due to Late Dumping Syndrome.
Hirose S; Iwahashi Y; Seo A; Sumiyoshi M; Takahashi T; Tamori Y
Intern Med; 2016; 55(9):1137-42. PubMed ID: 27150868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
